Page last updated: 2024-08-24

imiquimod and Lymphoma, Non-Hodgkin

imiquimod has been researched along with Lymphoma, Non-Hodgkin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchi, L; Campione, E; Chimenti, S; Citarella, L; Del Principe, I; Di Prete, M; Diluvio, L; Orlandi, A1
Bogeschdorfer, F; Gronau, S; Riechelmann, H1
Dahl, P; Damon, IK; DeGroot, HE; Goldman, E; Green, GM; Greer, PW; Lederman, ER; Li, Y; Paddock, CD; Zhao, H1

Reviews

1 review(s) available for imiquimod and Lymphoma, Non-Hodgkin

ArticleYear
[New substances in the therapy of head and neck cancer].
    Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7

    Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration

2006

Other Studies

2 other study(ies) available for imiquimod and Lymphoma, Non-Hodgkin

ArticleYear
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.
    Journal of medical case reports, 2016, Mar-11, Volume: 10

    Topics: Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Imiquimod; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Treatment Outcome; Vincristine

2016
Progressive ORF virus infection in a patient with lymphoma: successful treatment using imiquimod.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jun-01, Volume: 44, Issue:11

    Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Ecthyma, Contagious; Female; Humans; Imiquimod; Lymphoma, Non-Hodgkin

2007